Test Catalog

Test ID: TPMT3    
Thiopurine Methyltransferase (TPMT) Activity Profile, Erythrocytes

Useful For Suggests clinical disorders or settings where the test may be helpful

Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs

 

Detection of individuals with hyperactive TPMT activity who have therapeutic resistance to thiopurine drugs and may develop hepatotoxicity if treated with these drugs

Highlights

Individuals who are either homozygous or heterozygous for thiopurine methyltransferase (TPMT) deficiency are at risk of developing life-threatening myelosuppression or severe hematopoietic toxicity when placed on standard doses of azathioprine (AZA, Imuran), 6-mercaptopurine (6-MP, Purinethol), or 6-thioguanine (6-TG, Thioguanine Tabloid).

 

Individuals who have TPMT hyperactivity cannot achieve therapeutic levels with thiopurine drugs, and they may develop hepatotoxicity due to treatment with thiopurine drugs.

 

Determining a patient's TPMT status prior to starting therapy with a thiopurine drug is, therefore, important for purposes of calculating the optimal drug dosage.

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

TPMT Activity Profile, RBC

Aliases Lists additional common names for a test, as an aid in searching

Azathioprine toxicity
Imuran toxicity
Mercaptopurine (6-MP) toxicity
Purinethol toxicity
Thioguanine (6-TG) toxicity
Thiopurine resistance
Myelosuppression
Hematopoietic toxicity
TPMT (Thiopurine Methyltransferase)
TPMT Phenotype
Liver toxicity